Image-Guided Ablation of Neuroendocrine Tumor Liver Metastases

Abstract

Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms that require a multidisciplinary process to determine the most appropriate approach for patient management and therapy. Over time, the treatment algorithms have continuously evolved as the options have improved and changed. This manuscript reviews the current and potential role of image-guided ablation in the treatment of patients with metastatic NET to the liver. While some attention will be devoted to the basics of ablation, the focus will be on the role of image-guided ablation in these patients and issues specific to the treatment of NET's liver metastases with ablation.

Keywords

ablation - neuroendocrine tumor - symptoms

• References

• 1 Cavalcoli F, Rausa E, Conte D, Nicolini AF, Massironi S. Is there still a role for the hepatic locoregional treatment of metastatic neuroendocrine tumors in the era of systemic targeted therapies?. World J Gastroenterol 2017; 23 (15) 2640-2650
• 2 Surveillance, Epidemiology, and End Results (SEER) Program. Research Data (1973–2015), National Cancer Institute, DCCPS, Surveillance Research Program 2018. www.seer.cancer.gov . Accessed January 5, 2018
• 3 Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97 (04) 934-959
• 4 Yao JC, Hassan M, Phan A. , et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26 (18) 3063-3072
• 5 Ito T, Lee L, Jensen RT. Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies. Expert Opin Pharmacother 2016; 17 (16) 2191-2205
• 6 Jensen RTNJ, Oberg K. Neuroendocrine tumors. In: Feldman MFL, Brandt LJ. , eds. Sleisenger and Fordtran's Gastrointestinal Liver Diseases. Vol 1. Philadelphia, PA: Elsevier Saunders; 2015: 501-541
• 7 Norlén O, Stålberg P, Zedenius J, Hellman P. Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumours. Br J Surg 2013; 100 (11) 1505-1514
• 8 Saxena A, Chua TC, Sarkar A. , et al. Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach. Surgery 2011; 149 (02) 209-220
• 9 Frilling A, Akerström G, Falconi M. , et al. Neuroendocrine tumor disease: an evolving landscape. Endocr Relat Cancer 2012; 19 (05) R163-R185
• 10 Tomassetti P, Campana D, Piscitelli L. , et al. Endocrine tumors of the ileum: factors correlated with survival. Neuroendocrinology 2006; 83 (5-6): 380-386
• 11 Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee Jr FT, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why?. Radiographics 2014; 34 (05) 1344-1362
• 12 Potretzke TA, Ziemlewicz TJ, Hinshaw JL. , et al. Microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: a comparison of efficacy at a single center. J Vasc Interv Radiol 2016; 27 (05) 631-638
• 13 Brace CL, Laeseke PF, Sampson LA, Frey TM, van der Weide DW, Lee Jr FT. Microwave ablation with multiple simultaneously powered small-gauge triaxial antennas: results from an in vivo swine liver model. Radiology 2007; 244 (01) 151-156
• 14 Lubner MG, Brace CL, Ziemlewicz TJ, Hinshaw JL, Lee Jr FT. Microwave ablation of hepatic malignancy. Semin Intervent Radiol 2013; 30 (01) 56-66
• 15 Wright AS, Lee Jr FT, Mahvi DM. Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 2003; 10 (03) 275-283
• 16 Steinmüller T, Kianmanesh R, Falconi M. , et al; Frascati Consensus Conference participants Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2008; 87 (01) 47-62
• 17 Dodd III GD, Dodd NA, Lanctot AC, Glueck DA. Effect of variation of portal venous blood flow on radiofrequency and microwave ablations in a blood-perfused bovine liver model. Radiology 2013; 267 (01) 129-136
• 18 Grandhi MS, Lafaro KJ, Pawlik TM. Role of locoregional and systemic approaches for the treatment of patients with metastatic neuroendocrine tumors. J Gastrointest Surg 2015; 19 (12) 2273-2282
• 19 Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol 2011; 21 (12) 2584-2596
• 20 Correa-Gallego C, Fong Y, Gonen M. , et al. A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases. Ann Surg Oncol 2014; 21 (13) 4278-4283
• 21 Ding J, Jing X, Liu J. , et al. Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques. Clin Radiol 2013; 68 (06) 608-615
• 22 Liu Y, Li S, Wan X. , et al. Efficacy and safety of thermal ablation in patients with liver metastases. Eur J Gastroenterol Hepatol 2013; 25 (04) 442-446
• 23 Meloni MF, Chiang J, Laeseke PF. , et al. Microwave ablation in primary and secondary liver tumours: technical and clinical approaches. Int J Hyperthermia 2017; 33 (01) 15-24
• 24 Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients. Radiology 2009; 251 (03) 933-940
• 25 Livraghi T, Meloni F, Solbiati L, Zanus G. ; Collaborative Italian Group using AMICA system Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol 2012; 35 (04) 868-874
• 26 Felker ER, Lee-Felker SA, Ajwichai K. , et al. Intraductal cooling via a nasobiliary tube during radiofrequency ablation of central liver tumors reduces biliary injuries. AJR Am J Roentgenol 2015; 204 (06) 1329-1335
• 27 de Baere T, Deschamps F, Tselikas L. , et al. GEP-NETS update: interventional radiology: role in the treatment of liver metastases from GEP-NETs. Eur J Endocrinol 2015; 172 (04) R151-R166
• 28 Maithel SK, Fong Y. Hepatic ablation for neuroendocrine tumor metastases. J Surg Oncol 2009; 100 (08) 635-638
• 29 Akyildiz HY, Mitchell J, Milas M, Siperstein A, Berber E. Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up. Surgery 2010; 148 (06) 1288-1293 , discussion 1293
• 30 Jones NB, Shah MH, Bloomston M. Liver-directed therapies in patients with advanced neuroendocrine tumors. J Natl Compr Canc Netw 2012; 10 (06) 765-774
• 31 Taner T, Atwell TD, Zhang L. , et al. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection. HPB (Oxford) 2013; 15 (03) 190-195
• 32 Liang P, Dong B, Yu X. , et al. Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. AJR Am J Roentgenol 2003; 181 (05) 1319-1325
• 33 Takahashi H, Kahramangil B, Berber E. Local recurrence after microwave thermosphere ablation of malignant liver tumors: results of a surgical series. Surgery 2018; 163 (04) 709-713
• 34 Mazzaglia PJ, Berber E, Milas M, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery 2007; 142 (01) 10-19
• 35 Mohan H, Nicholson P, Winter DC. , et al. Radiofrequency ablation for neuroendocrine liver metastases: a systematic review. J Vasc Interv Radiol 2015; 26 (07) 935-942.e1
• 36 Bissonnette RT, Gibney RG, Berry BR, Buckley AR. Fatal carcinoid crisis after percutaneous fine-needle biopsy of hepatic metastasis: case report and literature review. Radiology 1990; 174 (3 Pt 1): 751-752
• 37 Majeed F, Porter TR, Tarantolo S, Duhachek-Stapelman A, Xie F, Elhendy A. Carcinoid crisis and reversible right ventricular dysfunction after embolization in untreated carcinoid syndrome. Eur J Echocardiogr 2007; 8 (05) 386-389
• 38 Raut CP, Kulke MH, Glickman JN, Swanson RS, Ashley SW. Carcinoid tumors. Curr Probl Surg 2006; 43 (06) 383-450
• 39 Sinha V, Dyer P, Shuvro RC, Geh JI, Karandikar S. Case of carcinoid crisis following a fine-needle biopsy of hepatic metastasis. Eur J Gastroenterol Hepatol 2009; 21 (01) 101-103
• 40 Woltering EA, Wright AE, Stevens MA. , et al. Development of effective prophylaxis against intraoperative carcinoid crisis. J Clin Anesth 2016; 32: 189-193
• 41 Gillams A, Cassoni A, Conway G, Lees W. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging 2005; 30 (04) 435-441
• 42 Massimino K, Harrskog O, Pommier S, Pommier R. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients. J Surg Oncol 2013; 107 (08) 842-846
• 43 Akahane M, Koga H, Kato N. , et al. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics 2005; 25 (Suppl (Suppl. 01) S57-S68
• 44 Rhim H, Yoon KH, Lee JM. , et al. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 2003; 23 (01) 123-134 , discussion 134–136
• 45 Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee Jr FT. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 2005; 236 (01) 132-139
• 46 Welch BT, Schmitz JJ, Atwell TD. , et al. Evaluation of infectious complications following percutaneous liver ablation in patients with bilioenteric anastomoses. Abdom Radiol (NY) 2017; 42 (05) 1579-1582
• 47 Howenstein MJ, Sato KT. Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms. Semin Intervent Radiol 2010; 27 (03) 285-295
• 48 Kim KR, Thomas S. Complications of image-guided thermal ablation of liver and kidney neoplasms. Semin Intervent Radiol 2014; 31 (02) 138-148
• 49 Meloni MF, Andreano A, Bovo G. , et al. Acute portal venous injury after microwave ablation in an in vivo porcine model: a rare possible complication. J Vasc Interv Radiol 2011; 22 (07) 947-951
• 50 Ziemlewicz TJ, Hinshaw JL, Lubner MG. , et al. Percutaneous microwave ablation of hepatocellular carcinoma with a gas-cooled system: initial clinical results with 107 tumors. J Vasc Interv Radiol 2015; 26 (01) 62-68
• 51 Chiang J, Willey BJ, Del Rio AM, Hinshaw JL, Lee FT, Brace CL. Predictors of thrombosis in hepatic vasculature during microwave tumor ablation of an in vivo porcine model. J Vasc Interv Radiol 2014; 25 (12) 1965-1971.e2
• 52 Chiang J, Cristescu M, Lee MH. , et al. Effects of microwave ablation on arterial and venous vasculature after treatment of hepatocellular carcinoma. Radiology 2016; 281 (02) 617-624
• 53 Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226 (02) 441-451
• 54 Andreano A, Galimberti S, Franza E. , et al. Percutaneous microwave ablation of hepatic tumors: prospective evaluation of postablation syndrome and postprocedural pain. J Vasc Interv Radiol 2014; 25 (01) 97-105.e1, 2
• 55 Dodd III GD, Napier D, Schoolfield JD, Hubbard L. . Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. AJR Am J Roentgenol 2005; 2005 (185) 51-57
• 56 Wah TM, Arellano RS, Gervais DA. , et al. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology 2005; 237 (03) 1097-1102